Literature DB >> 7903067

The spectrum of disease associated with a positive ANCA.

E A Murphy1, J G Fox, I Galbraith, R Madhok, J M Jones, H A Capell.   

Abstract

This is a retrospective analysis of all patients with a raised titre of ANCA in a single centre over a two-year period. Sixty-five patients were identified and clinical data is presented for 58 of these-34 male and 24 female. The median age is 56 years (13-83). Fourteen patients had Wegener's granulomatosis, 14 microscopic polyarteritis nodosa and 30 had other diagnoses. The patients with unexpectedly positive results are discussed in detail. This study confirms the sensitivity of ANCA in Wegener's granulomatosis and microscopic polyarteritis nodosa but suggests that the test is not as specific as initially claimed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903067     DOI: 10.1007/bf02231573

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

Review 1.  ANCA-associated renal disease.

Authors:  R J Falk
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

Review 2.  Autoantibodies in primary systemic vasculitis.

Authors:  C O Savage; C M Lockwood
Journal:  Adv Intern Med       Date:  1990

3.  Pitfalls with anti-neutrophil cytoplasmic antibodies (ANCA).

Authors:  L S De Clerck; J F Van Offel; W A Smolders; F A Empsten; C H Bridts; N Bourgeois; E Van Marck; U Timmermans; W J Stevens
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

4.  Diagnostic significance of anticytoplasmatic antibodies (ACPA/ANCA) in detection of Wegener's granulomatosis and other forms of vasculitis.

Authors:  K Andrassy; J Koderisch; R Waldherr; M Rufer
Journal:  Nephron       Date:  1988       Impact factor: 2.847

5.  Antibodies to neutrophil cytoplasmic antigen in systemic vasculitis.

Authors:  M C Venning; S Arfeen; A G Bird
Journal:  Lancet       Date:  1987-10-10       Impact factor: 79.321

6.  Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies.

Authors:  P Ronco; P Verroust; F Mignon; O Kourilsky; P Vanhille; A Meyrier; J P Mery; L Morel-Maroger
Journal:  Q J Med       Date:  1983

7.  Anti-myeloperoxidase antibodies in systemic vasculitis.

Authors:  S S Lee; D Adu; R A Thompson
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

8.  Association of autoantibodies to myeloperoxidase with different forms of vasculitis.

Authors:  J W Tervaert; R Goldschmeding; J D Elema; P C Limburg; M van der Giessen; M G Huitema; M I Koolen; R J Hené; T H The; G K van der Hem
Journal:  Arthritis Rheum       Date:  1990-08

9.  Polyarteritis group of systemic vasculitis--new diagnostic criteria.

Authors:  A C Leung; A McLay; H Mosley; J M Boulton Jones
Journal:  Scott Med J       Date:  1985-10       Impact factor: 0.729

10.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

View more
  1 in total

1.  Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey.

Authors:  Zeynep Ozbalkan; Sedat Kiraz; M Akif Ozturk; A Ihsan Ertenli; Sule Apras; Meral Calguneri
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.